About Allergan, Inc. (NYSE: AGN)
2525 Dupont Drive
Irvine, California, 92612
I.R.S. Employer Identification No.: 95-1622442
website: http://www.allergan.com/index.htm
Total Revenue: $ 4,919,400,000 (2010)
About Allergan (from Form 10-K):
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter products that enable people to live life to its greatest potential — to see more clearly, move more freely and express themselves more fully. Our diversified approach enables us to follow our research and development into new specialty areas where unmet needs are significant.
We discover, develop and commercialize specialty pharmaceutical, biologics, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries around the world. Our diversified business model includes products for which patients may be eligible for reimbursement and cash pay products that consumers pay for directly. Based on internal information and assumptions, we estimate that in fiscal year 2010, approximately 71% of our net product sales were derived from reimbursable products and 29% of our net product sales were derived from cash pay products.
We are a pioneer in specialty pharmaceutical, biologic and medical device research and development, with global efforts targeting products and technologies related to eye care, skin care, neuromodulators, medical aesthetics, obesity intervention, urology and neurology. In 2010, our research and development expenditures were approximately 16.7% of our product net sales or approximately $804.6 million. We supplement our own research and development activities with our commitment to identify and obtain new technologies through in-licensing, research collaborations, joint ventures and acquisitions.
We were founded in 1950 and incorporated in Delaware in 1977. Our principal executive offices are located at 2525 Dupont Drive, Irvine, California, 92612, and our telephone number at that location is (714) 246-4500. Our Internet website address is www.allergan.com.
FDA Accused of going soft on Allergan (AGN)
http://flucrazy.blogspot.com/2011/03/fda-accused-of-going-soft-on-allergan.html
200 Largest Pharmaceutical Companies in the World
http://flucrazy.blogspot.com/2011/02/flucrazy-200-200-largest-pharmaceutical.html
No comments:
Post a Comment